Headquartered in Ann Arbor, Michigan, Upkara is a biotechnology company striving to create a world with greater health equity and sustainability by reducing reliance on cold-chain to supply reagents, diagnostics, and pharmaceuticals. Upkara’s novel biomolecule stabilization technology is rapid, cost-effective, and broadly applicable, enabling suppliers to bring added value to their customers through easy-to-use, shelf-stable materials. The technology requires little to no optimization, can be used to stabilize complex mastermixes, has cycle times of less than 2 hours, and provides room-temperature stability and protection from temperature excursions. Upkara provides flexible access to their technology through custom manufacturing or out-licensing options. Upkara is currently seeking life science partners for its commercial offering and pharmaceutical collaborators with an interest in exploring the technology for use in therapeutics and vaccines.